A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals.

Autor: Alugubelli YR; Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA., Geng ZZ; Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA., Yang KS; Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA., Shaabani N; Sorrento Therapeutics, Inc. San Diego, CA, 92121, USA., Khatua K; Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA., Ma XR; Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA., Vatansever EC; Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA., Cho CC; Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA., Ma Y; Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA., Xiao J; Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA., Blankenship LR; Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA., Yu G; Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA., Sankaran B; Molecular Biophysics and Integrated Bioimaging, Berkeley Center for Structural Biology, Laurence Berkeley National Laboratory, Berkeley, CA, 94720, USA., Li P; Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX, 77843, USA., Allen R; Sorrento Therapeutics, Inc. San Diego, CA, 92121, USA., Ji H; Sorrento Therapeutics, Inc. San Diego, CA, 92121, USA. Electronic address: hji@sorrentotherapeutics.com., Xu S; Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA. Electronic address: shiqing.xu@tamu.edu., Liu WR; Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, 77843, USA; Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX, 77843, USA; Institute of Biosciences and Technology and Department of Translational Medical Sciences, College of Medicine, Texas A&M University, Houston, TX, 77030, USA; Department of Molecular and Cellular Medicine, College of Medicine, Texas A&M University, College Station, TX, 77843, USA. Electronic address: wsliu2007@tamu.edu.

Publikováno v: European journal of medicinal chemistry [Eur J Med Chem] 2022 Oct 05; Vol. 240, pp. 114596. Date of Electronic Publication: 2022 Jul 08.

[DIABETIC RETINOPATHY AND ITS TREATMENT].

Autor: DENEUMANN PS

Publikováno v: Archivos de oftalmologia de Buenos Aires [Arch Oftalmol B Aires] 1963 Jul; Vol. 38, pp. 207-18.

PHOTOALLERGY AND PHOTOSENSITIVITY DUE TO SYSTEMICALLY ADMINISTERED DRUGS.

Autor: STORCK H

Publikováno v: Archives of dermatology [Arch Dermatol] 1965 May; Vol. 91, pp. 469-82.

CORNEAL AND LENTICULAR OPACITIES IN THE EYES OF RATS FOLLOWING LONG-TERM ADMINISTRATION OF SULFONYLUREA DERIVATIVES. A PRELIMINARY REPORT.

Autor: WRIGHT HN

Publikováno v: Diabetes [Diabetes] 1963 Nov-Dec; Vol. 12, pp. 550-4.

A REVIEW OF THE HISTORY OF THE TREATMENT OF DIABETES MELLITUS AND THE SEARCH FOR ORAL HYPOGLYCAEMIC AGENTS.

Autor: PADFIELD CJ

Publikováno v: Guy's Hospital reports [Guys Hosp Rep] 1964; Vol. 113, pp. 45-54.